autoimmune disease

Biotech

Horizon racks up 2nd win in Sjögren's to claim unique double

Horizon has chalked up another win for its CD40 candidate dazodalibep, linking the molecule to improved outcomes in a second Sjögren’s syndrome study.
Nick Paul Taylor Jan 18, 2023 9:30am

Lilly pays $55M to ride TRex into regulatory T-cell space

Jan 9, 2023 9:10am

Vera finally snags a win for Merck KGaA kidney disease castoff

Jan 3, 2023 4:01pm

Gilead hopes to evoke new autoimmune treatments with $659M deal

Jan 3, 2023 11:11am

In struggling Vallon, GRI Bio spots opportunity to reach Nasdaq

Dec 14, 2022 8:27am

AbbVie connects with HotSpot for $40M cash

Dec 6, 2022 10:50am